#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16986	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2374	870.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1566	1566	C	1101	C,G	1100,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	16986	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2374	870.7	0	HET	.	.	.	C1450T,A	.	1450	1450	C	1832	1832	C	1132	C,T,A	880,251,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27608	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3822	896.1	0	.	n	.	0	T695C	SNP	695	695	T	1153	1153	C	1031	C,T,A,G	1024,3,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27608	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3822	896.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1795	1795	A	1144	A,C,G	1141,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27608	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3822	896.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2429	2429	C	986	C,T,A	982,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27608	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3822	896.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2503	2503	A	832	A	832	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27608	23S	2890	2890	99.9	23S.l6.c17.ctg.1	3822	896.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	3055	3055	C	944	C,T,G,A	939,2,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2472	folP	855	855	100.0	folP.l6.c4.ctg.1	2046	150.2	1	SNP	p	R229S	0	.	.	685	687	CGC	1280	1282	CGC	217;217;219	C;G;C	217;217;219	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6268	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3748	208.2	1	SNP	p	S91F	0	.	.	271	273	TCC	744	746	TCC	244;242;242	T;C;C,A	244;242;241,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6268	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3748	208.2	1	SNP	p	D95N	0	.	.	283	285	GAC	756	758	GAC	248;248;250	G;A;C	248;248;250	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	6268	gyrA	2751	2751	99.89	gyrA.l15.c17.ctg.1	3748	208.2	1	SNP	p	D95G	0	.	.	283	285	GAC	756	758	GAC	248;248;250	G;A;C	248;248;250	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	2304	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1854	154.8	1	SNP	p	G45D	0	.	.	133	135	GGC	808	810	GGC	268;265;266	G,T;G,C;C	267,1;264,1;266	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1256	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1394	112.1	0	.	n	.	0	A197.	DEL	197	197	A	773	773	A	260	A	260	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5776	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3468	207.8	1	SNP	p	D86N	0	.	.	256	258	GAC	832	834	GAC	267;268;266	G;A,C;C	267;266,2;266	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5776	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3468	207.8	1	SNP	p	S88P	0	.	.	262	264	TCC	838	840	TCC	270;273;273	T;C;C,A	270;273;272,1	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5038	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3169	198.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1821	1823	GGC	314;310;307	G,T;G;C,G,A	312,2;310;305,1,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4578	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	199.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1506	1508	GCA	266;267;268	G,A;C,A;A	265,1;266,1;268	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4578	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	199.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1509	1511	ATC	263;262;265	A;T;C	263;262;265	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4578	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	199.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1521	1523	GTG	260;262;262	G;T;G,C	260;262;261,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4578	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	199.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1521	1523	GTG	260;262;262	G;T;G,C	260;262;261,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4578	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	199.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2025	2027	ACC	229;230;233	A,C,G;C;C	226,2,1;230;233	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4578	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	199.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2079	2081	GCG	246;245;248	G;C,T,G;G	246;243,1,1;248	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4578	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	199.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2079	2081	GCG	246;245;248	G;C,T,G;G	246;243,1,1;248	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4578	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	199.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2202	2204	GGC	243;245;246	G,T;G,T;C	242,1;244,1;246	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4578	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	199.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2211	2213	GGC	246;249;253	G,T;G;C,T,A	245,1;249;251,1,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4578	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2861	199.6	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2229	2231	CTG	269;269;266	C;T;G	269;269;266	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	6132	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3713	206.1	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1880	1882	CCG	218;220;219	C;C,T;G	218;219,1;219	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2920	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2368	153.8	0	.	p	.	0	S22G	NONSYN	64	66	AGC	675	677	GGC	219;213;214	G;G;C	219;213;214	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2920	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2368	153.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	857	857	C	206	C,A	205,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	227	90.75	porB1a.l15.c4.ctg.2	667	23.1	0	.	p	.	0	V258L	NONSYN	772	774	GTA	15	17	TTA	28;34;37	T,G;T;A	27,1;34;37	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	227	90.75	porB1a.l15.c4.ctg.2	667	23.1	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	60	62	CAT	74;74;74	C;A;T	74;74;74	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	227	90.75	porB1a.l15.c4.ctg.2	667	23.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	63	65	AGT	74;74;74	A;G;T	74;74;74	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	227	90.75	porB1a.l15.c4.ctg.2	667	23.1	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	72	74	TAC	74;74;74	T;A;C	74;74;74	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	227	90.75	porB1a.l15.c4.ctg.2	667	23.1	0	.	p	.	0	R307E	NONSYN	919	921	AGA	162	164	GAA	2;2;2	G;A;A	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	227	90.75	porB1a.l15.c4.ctg.2	667	23.1	0	.	p	.	0	T311A	NONSYN	931	933	ACA	174	176	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	227	90.75	porB1a.l15.c4.ctg.2	667	23.1	0	.	p	.	0	F314I	NONSYN	940	942	TTC	183	185	ATC	3;3;3	A;T;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	227	90.75	porB1a.l15.c4.ctg.2	667	23.1	0	.	p	.	0	A316S	NONSYN	946	948	GCG	189	191	TCG	3;3;3	T;C;G	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	227	90.75	porB1a.l15.c4.ctg.2	667	23.1	0	.	p	.	0	V318A	NONSYN	952	954	GTC	195	197	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	227	90.75	porB1a.l15.c4.ctg.2	667	23.1	0	.	p	.	0	G319S	NONSYN	955	957	GGC	198	200	AGC	3;3;3	A;G;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	227	90.75	porB1a.l15.c4.ctg.2	667	23.1	0	.	p	.	0	G320A	NONSYN	958	960	GGT	201	203	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	326	porB1a	984	227	90.75	porB1a.l15.c4.ctg.2	667	23.1	0	.	p	.	0	G322V	NONSYN	964	966	GGT	207	209	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3278	porB1b	1035	1035	98.57	porB1b.l6.c17.ctg.1	2230	183.2	0	.	p	.	0	R143G	NONSYN	427	429	AGA	947	949	GGA	245;249;254	G;G,A;A	245;248,1;254	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3278	porB1b	1035	1035	98.57	porB1b.l6.c17.ctg.1	2230	183.2	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1151	1151	T	266	T	266	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3278	porB1b	1035	1035	98.57	porB1b.l6.c17.ctg.1	2230	183.2	1	SNP	p	G120K	0	.	.	358	360	GGT	878	880	GGT	263;264;264	G;G;T,A,G,C	263;264;261,1,1,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3278	porB1b	1035	1035	98.57	porB1b.l6.c17.ctg.1	2230	183.2	1	SNP	p	A121N	0	.	.	361	363	GCC	881	883	GCC	264;266;266	G,A;C,T;C	262,1;265,1;266	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3278	porB1b	1035	1035	98.57	porB1b.l6.c17.ctg.1	2230	183.2	1	SNP	p	A121D	0	.	.	361	363	GCC	881	883	GCC	264;266;266	G,A;C,T;C	262,1;265,1;266	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11136	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	5337	260.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1640	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1344	151.7	1	SNP	p	V57M	1	.	.	169	171	ATG	682	684	ATG	289;290;288	A;T,G;G	289;289,1;288	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	M177T	NONSYN	529	531	ATG	1111	1113	ACG	859;852;846	A,T;C;G	858,1;852;846	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	1132	1134	GAC	767;766;763	G,T;A,G,C;C,G	765,2;764,1,1;762,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	T190M	NONSYN	568	570	ACG	1150	1152	ATG	763;761;762	A;T;G	762;761;761	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	L194S	NONSYN	580	582	TTA	1162	1164	TCA	770;763;763	T,C,G;C,A;A	768,1,1;761,2;763	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1207	1209	CAG	764;750;746	C,A;A;G,T,A	763,1;749;744,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1228	1230	CTT	730;723;720	C,T,A;T,C;T	727,1,1;722,1;719	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1249	1251	AGT	727;726;728	A;G;T,A	727;725;727,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1318	1320	CCG	775;782;784	C,T;C,T;G,C,A	774,1;781,1;782,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1420	1422	TCG	957;957;957	T;C,A;G,T	957;956,1;956,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1591	1593	AAA	402;394;391	A;A;A	402;393;390	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1594	1596	AAG	391;387;382	A;A;G	390;386;382	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1609	1611	CAC	342;342;345	C;A;C	342;342;345	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1648	1650	GAA	449;456;459	G;A,C;A,G,C	449;454,2;457,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1726	1728	ACG	644;643;647	A;C;G,T	644;643;646,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1777	1779	ATT	806;811;813	A,T,C;T;T	804,1,1;811;813	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1780	1782	AGT	821;822;829	A;G,A,T;T	821;820,1,1;829	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1819	1821	CTA	870;868;871	C,G;T;A	869,1;868;871	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1861	1863	AAT	858;862;862	A,T;A;T,G	856,1;861;861,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1930	1932	TCA	751;748;744	T,G,C;C;A,T	749,1,1;748;743,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1954	1956	ATG	704;707;713	A,C;T;G,A	703,1;707;712,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2248	2250	ACC	871;868;871	A;C,G;C,T	871;867,1;870,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	17180	tetM	1920	1920	96.3	tetM.l15.c17.ctg.1	3003	712.7	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2344	2346	GAA	858;865;856	G;A;A	857;864;855	.	Tetracycline resistance
